Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026)
Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
739.13 Mn |
538.51 Mn |
34.30 Mn |
13,316.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
13,316.00 |
| Dec 31, 2025 |
20,663.00 |
| Sep 30, 2025 |
89,544.00 |
| Jun 30, 2025 |
74,840.00 |
| Mar 31, 2025 |
48,154.00 |
| Dec 31, 2024 |
-1,560.00 |
| Sep 30, 2024 |
-54,720.00 |
| Jun 30, 2024 |
-42,000.00 |
| Mar 31, 2024 |
-7,155.00 |
| Dec 31, 2023 |
150,039.00 |
| Sep 30, 2023 |
-15,366.00 |
| Jun 30, 2023 |
4.57 Mn |
| Mar 31, 2023 |
-68,376.00 |
| Dec 31, 2022 |
-155,180.00 |
| Sep 30, 2022 |
-10,881.00 |
| Jun 30, 2022 |
-4.57 Mn |
| Mar 31, 2022 |
34,933.00 |
| Dec 31, 2021 |
10,268.00 |
| Sep 30, 2021 |
6,856.00 |
| Jun 30, 2021 |
3,932.00 |
